344 related articles for article (PubMed ID: 7860138)
21. Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.
Varga MG; Cai H; Waterboer T; Murphy G; Shimazu T; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Abnet CC; Tsugane S; Cai Q; Zheng W; Pawlita M; Shu XO; Epplein M
Dig Dis Sci; 2018 Oct; 63(10):2765-2772. PubMed ID: 29948559
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
23. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
24. Role of serum EBV-VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population.
Wang Z; Lv Z; Ding H; Xu Q; Sun L; Jing J; Yuan Y
Cancer Med; 2018 Nov; 7(11):5760-5774. PubMed ID: 30306734
[TBL] [Abstract][Full Text] [Related]
25. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans.
Shin WS; Kang MW; Kang JH; Choi MK; Ahn BM; Kim JK; Sun HS; Min KW
Am J Clin Pathol; 1996 Feb; 105(2):174-81. PubMed ID: 8607441
[TBL] [Abstract][Full Text] [Related]
27. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus serology and gastric cancer incidence and survival.
Koshiol J; Qiao YL; Mark SD; Dawsey SM; Abnet CC; Kamangar F; Lennette ET; Dong ZW; Taylor PR
Br J Cancer; 2007 Dec; 97(11):1567-9. PubMed ID: 17987041
[TBL] [Abstract][Full Text] [Related]
29. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma.
Wong MM; Lye MS; Cheng HM; Sam CK
Asian Pac J Allergy Immunol; 2005 Mar; 23(1):65-7. PubMed ID: 15997877
[TBL] [Abstract][Full Text] [Related]
31. Frequency of Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan.
Hsieh LL; Lin PJ; Chen TC; Ou JT
Cancer Lett; 1998 Jul; 129(2):125-9. PubMed ID: 9719452
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].
Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
[TBL] [Abstract][Full Text] [Related]
34. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma.
Cai YL; Li J; Lu AY; Zheng YM; Zhong WM; Wang W; Gao JQ; Zeng H; Cheng JR; Tang MZ
Asian Pac J Cancer Prev; 2014; 15(5):2001-6. PubMed ID: 24716925
[TBL] [Abstract][Full Text] [Related]
38. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
39. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus and gastric carcinoma.
Osato T; Imai S
Semin Cancer Biol; 1996 Aug; 7(4):175-82. PubMed ID: 8946601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
